Related Experiment Videos
Risk and benefit associated with radiation dose in breast screening programmes--an update
1Edinburgh University Department of Medical Physics and Medical Engineering, Western General Hospital, UK.
The British Journal of Radiology
|August 1, 1995
Summary
This study estimates risks for women in the UK Breast Screening Programme, finding that radiation risks from screening rarely exceed detection benefits. Updated data suggests an improved benefit-risk balance for most participants.
Area of Science:
- Radiological Sciences
- Medical Physics
- Public Health
Background:
- The UK Breast Screening Programme aims to detect breast cancer early.
- Estimating radiation risks versus cancer detection benefits is crucial for screening optimization.
- Previous assessments indicated minimal risk-benefit imbalance for a very small subset of women.
Purpose of the Study:
- To update and refine estimates of the risk of radiation-induced cancer versus cancer detection probability for women in the UK Breast Screening Programme.
- To incorporate new data on cancer induction and age-specific risks.
- To evaluate the implications for screening schedules and ongoing trials.
Main Methods:
- Analysis of individual breast dose variations based on breast size and imaging parameters.
- Inclusion of updated data on radiation-induced cancer risk, considering age at exposure.
- Comparison of updated risk-benefit assessments with previous findings.
Main Results:
- The updated analysis generally shows an improved balance of benefit against radiation risk compared to previous estimates.
- For the vast majority of women, the probability of cancer detection outweighs the risk of radiation-induced cancer.
- A very small number of women, approximately one in a million, may fall into categories where induction risk could exceed detection probability.
Conclusions:
- The overall risk-benefit balance for the UK Breast Screening Programme is generally reassuring.
- Updated data and methods confirm the safety and efficacy of the programme for most participants.
- The findings support current screening practices and provide reassurance for alternative schedules and trials.